All News

New pediatric urology chiefs have been named at New York-Presbyterian/Morgan Stanley Children's Hospital, New York and the University of Wisconsin, Madison.

Hospitals have virtually given up the search for solo physicians, as a symbol of America's tradition of independent medical practice fades from the scene, a new survey indicates.

Urinary incontinence may be a common problem among young women who have never been pregnant, according to a study in the Annals of Internal Medicine.

Extreme cuts to funding for medical imaging scans in the Medicare fee schedule proposed rule for 2013 are unnecessary, unfounded, and undermine care for the most sick or injure seniors, according to the American College of Radiology.

Physicians should discuss the benefits and risks of PSA testing with their asymptomatic male patients who have life expectancies of greater than 10 years, but the risks outweigh the benefits of men with shorter life expectancies, according to a new evidence-based provisional clinical opinion on prostate cancer screening issued by the American Society of Clinical Oncology.

Loyola University Health System in Maywood, IL has opened a multidisciplinary center to treat women with pelvic floor disorders.

Use of cranberry-containing products appears to be associated with prevention of urinary tract infections in some individuals, according to a meta-analysis published in the Archives of Internal Medicine (2012; 172:988-96).

Older women with acute pyelonephritis can be successfully and safely treated with oral ciprofloxacin (Cipro, Proquin) for 7 days, Swedish researchers report.

The diabetes drug pioglitazone (Actos) was associated with a 22% increased risk of developing bladder cancer in a recent study, supporting earlier research findings of a link between the drug and bladder cancer.

Male hormonal contraceptives applied daily to the skin appear to reduce sperm production, according to a new study presented at the Endocrine Society annual meeting in Houston.

American Medical Systems (Minnetonka, MN) has signed a co-development agreement with Allergan, Inc. to jointly develop and seek regulatory approval for the delivery of onabotulinumtoxinA (Botox) using the AMS JetTouch system for treatment of overactive bladder.

U.S. Senator Barbara Boxer (D-CA) and Congressman Elijah Cummings (D-MD) recently introduced the Prostate Cancer Detection Research and Education Act, legislation that would improve research and detection of prostate cancer.

A recent study has pinpointed four genes linked to prostate cancer, a finding that researchers say could significantly improve diagnosis and treatment by identifying slow-growing cancers that do not need to be treated and by developing targeted therapies for aggressive forms of the disease.

The FDA has approved the once-daily oral beta-3 adrenergic agonist mirabegron (Myrbetriq) for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Scientists at Washington University School of Medicine in St. Louis have found new clues to why some urinary tract infections recur persistently after multiple rounds of treatment.

Testosterone replacement therapy may result in weight reduction and improvement in symptoms of metabolic syndrome, according to separate studies presented at the Endocrine Society annual meeting in Houston.

The FDA recently granted pre-market approval to Prostate Health Index (phi), a noninvasive blood test that manufacturer Beckman Coulter, Inc. claims is 2.5 times more specific in detecting prostate cancer than PSA in patients with PSA values in the 4.0 to 10.0 ng/mL range.

The American Institute of Ultrasound in Medicine (AIUM) and the AUA have announced the collaborative development of practice and training guidelines in the practice of urologic ultrasound, which has led to the availability of practice accreditation through the AIUM.

Patients who receive a mid-urethral sling have less than half the risk of urinary incontinence after prolapse surgery than those who do not receive a sling, according to a recent study.

Some 190,000 men in the U.S. with non-metastatic prostate cancer were receiving continuous androgen deprivation therapy (ADT) at the end of 2008.

While on the surface, it may not seem to matter, there are some important differences between debit and credit cards, and reasons why you should use one form of payment over the other.

Whenever an employee leaves, you incur expenses to advertise the open position and set up and train a new employee. And, of course, there can be productivity losses in the interim.

Most urologists say they've already seen reaction to the report's release and the resulting news coverage. Many are concerned that the USPSTF recommendation will give men another excuse to avoid the doctor's office.

In a recent audit of urodynamics charges, Medicare recognized some codes but not others, and the documentation for all services that were reviewed only included the report from the urodynamics machine. This review pointed out the lack of understanding of these codes by payers and physicians.

Analyses of data from the Prostate Cancer Outcomes Study (PCOS) show that among men with localized prostate cancer, treatment by radical prostatectomy results in significantly better 15-year overall and disease-specific survival outcomes compared with external beam radiotherapy (EBRT).

Treatment with the dual 5-alpha- reductase inhibitor dutasteride (Avodart) does not compromise the utility of PSA to detect progression of disease in patients with low-risk localized prostate cancer who are being managed with active surveillance.

Combining the results of the diagnostic and first-surveillance prostate biopsies provides useful information about the risk of progression in patients being managed by active surveillance.